On Television
Our Locations
- Pennsylvania Address
(215) 772-1000 - New Jersey Address
(856) 662-1180 - New York Address
(212) 986-6200 - Google Map
Cancer Attorneys
Philadelphia, Pennsylvania, New Jersey, New York and Nationwide

Missed/delayed diagnoses - cancer malpractice
Medical errors involving cancer cases are relatively common, whether missed or delayed diagnosis of the disease or, as in a recently publicized Philadelphia case, botched surgeries by doctors and their staffs. Such incidents of medical malpractice can lead to serious injury and death.
A missed or delayed diagnosis of cancer can lead to a spread of the cancer, causing disfiguring surgery, unnecessary chemotherapy and radiation therapy. One study estimated that 128,000 Americans annually are injured because of a cancer misdiagnosis, with many of them dying.
Other forms of medical malpractice also occur in cancer cases, such as the recent revelation that at least 92 surgical procedures involving prostate cancer -- known as brachytherapy -- were botched at a Veterans Affairs hospital in Philadelphia. (Read story.)
If you or a loved one were the victim of medical malpractice involving a cancer case, you may want to contact a cancer attorney for a free evaluation of your case.
The series of medical errors at the Philadelphia VA hospital, widely reported in June 2009, included a surgeon mistakenly implanting radioactive “seeds” not in cancerous prostates but in healthy organs, including patients’ bladders and rectums. In other cases the doses of radiation were either too high or too low.
A study reported in the online journal Cancer concluded that roughly 12 percent of cancer patients in the United States are initially misdiagnosed. It was this study that estimated that 128,000 people each year suffer some degree of "harm," ranging from having to undergo a second round of tests to consequences that are fatal.
Dr. Stephen S. Raab, a professor at the University of Pittsburgh School of Medicine who authored the study, said: "I want to make clear that the major consequence is not that patients unnecessarily have organs removed or have a false diagnosis of cancer, but rather that they have cancer and it is not diagnosed."
The study concluded that misdiagnoses were caused by improper blood and tissue sampling and inaccurate reading of laboratory test results. Breast and colon cancer are among the more common forms of cancer that go undetected because of error.
A later study found that women older than 70 are "under-diagnosed, under-staged, and under-treated" for cancer compared with younger women. Women in the older age group make up fully one-third of all breast cancer patients. (Read the article.)
Kline & Specter, P.C., a law firm with some 30 attorneys – several of them also highly skilled doctors – has broad experience and success in litigating cancer cases, winning substantial jury verdicts and settlements in Philadelphia and the surrounding suburban counties.
Breast Cancer. In one case tried by Tom Kline, a jury in Lehigh County awarded $33.1 million to a woman whose doctor and a company that provided mammography services failed to timely diagnose her breast cancer. She died as a result. (See the Welteroth Case.)
In a 2003 trial later featured on ABC’s Nightline, Kline won a $3 million verdict for the family of a woman, Dagmar Lackman, who died because of a delayed breast cancer diagnosis.
Colon Cancer. In a colon cancer case, the law firm won a verdict of $8.25 million in Delaware County Court for a man whose cancer was initially missed, leading to his death.
In another case, Kline & Specter reached a settlement on behalf of the family of Stephen Little, the former WBA super middleweight champion, who died of cancer after a misdiagnosis led to a 10-month delay in treating his colon cancer. Little, of Reading, married and the father of six, died at age 34.
Click here to view News Articles about cancer cases handled by Kline & Specter attorneys.
Resources
Read about the cancer misdiagnosis study
Read about the age-inequities cancer study
Breaking News
- Tom Kline interviewed on botched VA prostate cancer cases, Fox News 6/22/09
- Tom Kline on Philadelphia VA cancer treatment problems, Fox News 8/13/08
- A genetic test that predicts whether colon cancer will return in certain patients will have a significant impact on treatment options, say researchers. The test predicts cancer recurrence risk but does not meet a secondary goal of predicting a patient's response to standard chemotherapy after surgery. The test could be available starting in 2010. One expert says the test is not perfect but is a good first step. (Full story)
- Farrah Fawcett has brought national attention to her fight against anal cancer since being diagnosed in 2006. The National Cancer Institutes estimates that in 2008, 5,070 new cases of anal cancer were diagnosed, and 680 people died from the disease. Medical experts say early detection is the key to fighting anal cancer, and that when it is caught early, it responds well to radiation and chemotherapy. (Full story)
- The U.S. Supreme Court has dismissed cigarette giant Philip Morris's appeal of a $79.5 million punitive damage verdict awarded to the widow of a longtime smoker who died of lung cancer.
In a terse one-sentence ruling, the high court allowed to stand a decade-old penalty imposed against the company by an Oregon jury. The widow’s husband was a two-pack-a-day smoker of Marlboro cigarettes, the premier Philip Morris brand. Because the three appeals took 10 years, the award has ballooned to nearly double the original sum because of compounding interest, and now totals $145 million. (Full story)
- A rare cancer, called inflammatory breast cancer or IBC, is a more aggressive form that tends to strike younger women. The biggest problem is that since few women even know about it, it's not being caught until very late. Inflammatory breast cancer accounts for just 1 percent to 5 percent of all breast cancer cases in the U.S., but by the time it's detected, it is usually at stage 3 or 4. (Full story)
- An Indiana jury awards a woman $8.1 million after finding that her odds of beating cancer were greatly reduced when a podiatrist failed to test tissue from an excised growth. The local podiatrist removed a growth from her big toe, but later said there was not enough tissue for testing. However, three podiatrists who reviewed the case concluded there should have been enough tissue for the test and the sample was likely lost in an office move. The 37-year-old mother of two is now in stage three of the cancer, and has a 17 percent chance of living another 12 years. (Full Story)




























